Remedent (Remedent) EBIT per Share : $-0.01 (TTM As of Dec. 2020)

View and export this data going back to 2000. Start your Free Trial

What is Remedent EBIT per Share?

Remedent's EBIT per Share for the three months ended in Dec. 2020 was $0.01. Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2020 was $-0.01.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Remedent's EBIT per Share or its related term are showing as below:

REMI's 3-Year EBIT Growth Rate is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 6.7
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

Remedent's EBIT for the three months ended in Dec. 2020 was $0.10 Mil.

Remedent EBIT per Share Historical Data

The historical data trend for Remedent's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Remedent EBIT per Share Chart

Remedent Annual Data

Trend

Mar11

Mar12

Mar13

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

EBIT per Share

Get a 7-Day Free Trial

0.01

0.04

0.11

-0.04

Remedent Quarterly Data
	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20
EBIT per Share	Get a 7-Day Free Trial															-0.01	-0.02	-	-	0.01

Remedent EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Remedent's EBIT per Share for the fiscal year that ended in Mar. 2020 is calculated as

	EBIT per Share		(A: Mar. 2020 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-0.838	/	19.996
=	-0.04

Remedent's EBIT per Share for the quarter that ended in Dec. 2020 is calculated as

	EBIT per Share		(Q: Dec. 2020 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	0.102	/	19.996
=	0.01

EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.01

Remedent (OTCPK:REMI) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Remedent EBIT per Share Related Terms

Thank you for viewing the detailed overview of Remedent's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Remedent (Remedent) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Remedent Inc (OTCPK:REMI) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

Zuiderlaan 1-3, Box 8, Ghent, BEL, 9000

Website

https://www.remedent.com

Remedent Inc is a manufacturer of cosmetic dentistry products in Europe. The company is engaged in the research, development, and manufacturing of oral care and cosmetic dentistry products. It designs, develops, manufactures, and distributes cosmetic dentistry products, including a full line of professional dental products that are distributed in Europe, Asia, the Middle East, and the United States. The product line of the company includes SmileWise, the SmileMe mirror, and the Condor intra-oral 3D scanner.

Executives

Stuart Steinberg	10 percent owner	85 BELLEVUE AVENUE, RYE NY 10580
Marxe Austin W & Greenhouse David M	10 percent owner	C/O SPECIAL SITUATIONS FUNDS, 527 MADISON AVENUE, SUITE 2600, NEW YORK NY 10022
Gruber & Mcbaine Capital Management Llc	10 percent owner	234 VAN NESS, STE 5, SAN FRANCISCO CA 94133
Stephen Farley Ross	director, officer: CFO; Secretary	XAVIER DE COCKLAAN 42 DEURLE C9 9831
Fred Kolsteeg	director	XAVIER DE COCKLAAN 42 DEURLE C9 9831
Acker Philippe Van	director	C/O REMEDENT, INC. XAVIER DE COCKLAAN 42 9831 DEURLE C9 9831
Robin List	other: Former Officer and Director	XAVIER DE COCKLAAN 42 DEURLE C9 9831
Roger Leddington	officer: Sr VP & Head of US Marketing	C/O REMEDENT, INC. XAVIER DE COCKLAAN 42 DEURLE C9 9831
Guy Devreese	director, officer: Chairman of the Board	XAVIER DE COCKLAAN 42 DEURLE C9 9831
Judd Darrin Hoffman	officer: VP Worldwide Sales/Operations	702A JUANITA AVENUE REDONDO BEACH CA 90277
Nv Lausha	10 percent owner	C/O REMEDENT, INC. XAVIER DE COCKLAAN 42 9831 DEURLE C9 9831

Remedent (Remedent) Headlines

From GuruFocus

Making Money from Smiles

By Frank Lind Frank Lind • 05-26-2011